Evaluation of the Immune Response to a 2-Dose Measles Vaccination Schedule Administered at 6 and 9 Months of Age to HIV-Infected and HIV-Uninfected Children in Malawi
The Journal of infectious diseases2008Vol. 198pp. 1457-1465
170
f.2008theevaluation
Abstract
Abstract. Background. The World Health Organization recommends that infants at high risk for developing measles before 9 months of age, including human immunod